Skip to content
Daily VIP View

Administering Pluripotent Cells in Utero to Babies with Neural Tube Defect Boosts Quality of Life, Study Reveals

A pioneering research effort has revealed that providing pluripotent cells to fetuses affected by spina bifida while undergoing fetal surgery can be a "significant breakthrough" in managing prenatal disorders.

Trial Details and Safety

The US-based trial involved six unborn babies with a severe neural tube defect. Surgeons applied mother's placental stem cells to the surface of the baby's spinal cord while the defect was being closed.

Significantly, the stem cell application demonstrated a favorable safety profile. Researchers confirmed that the therapy did not induce tumors, interfere with wound healing, or prevent the reversal of associated brain abnormalities.

Positive Developments

Post-birth MRI scans confirmed a successful correction of brainstem displacement in every participant. This brain structure normalization is strongly associated with better mobility and function.

"In the event it allows more children to achieve ambulation who previously could not, it may emerge as the conventional approach," said the lead researcher. "The results are super exciting and create a pathway toward numerous possible novel therapies."

Future Implications and Hope

Experts not involved in the trial indicated that additional validation of these noted improvements could herald a "fresh chapter" in fetal surgery. The potential to improve nerve function impairment seen in utero is viewed as a paradigm-shifting aim.

Particularly welcome would be improvements in bladder and bowel function, which are typical difficulties for individuals living with this condition.

Future Directions

Although this preliminary study was small in scale, its safety demonstration and positive signals offer a robust platform for larger, more comprehensive studies. The addition of cellular treatment with proven prenatal surgical methods offers substantial hope for changing life trajectories for future generations with myelomeningocele.

DC
Written by

Darryl Contreras

Emily Hartfield is a seasoned journalist with a passion for uncovering hidden stories and sharing them with a global audience.

Daily VIP View

Type to search articles.